FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083631 [Registered on: 28/03/2025] Trial Registered Prospectively
Last Modified On: 27/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Integrative Psychotherapy for Substance Use Disorders with Antisocial Behavior 
Scientific Title of Study   Application of Integrative Psychotherapy on Emotional Dysregulation, Self-Serving Cognitive Distortions, Executive Dysfunction among Patients of Substance Use Disorders with Antisocial Behavior: A Randomized Controlled Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jasar Khan 
Designation  PhD Scholar  
Affiliation  Central Institute of Psychiatry 
Address  Department of Clinical Psychology, Central Institute of Psychiatry, Kanke, Ranchi

Ranchi
JHARKHAND
834006
India 
Phone  7011326859  
Fax    
Email  psy.jasar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sanjay Kumar Munda 
Designation  Professor of Psychiatry 
Affiliation  Central Institute of Psychiatry 
Address  Department of Psychiatry, Central Institute of Psychiatry, Kanke Ranchi

Ranchi
JHARKHAND
834006
India 
Phone  8797641082  
Fax    
Email  drsanjaymunda@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Masroor Jahan 
Designation  Additional Professor 
Affiliation  Ranchi Institute of Neuro-Psychiatry and Allied Sciences 
Address  Department of Clinical Psychology, Ranchi Institute of Neuro-Psychiatry and Allied Sciences, Ranchi

Ranchi
JHARKHAND
834006
India 
Phone  7903413032  
Fax    
Email  masroorjahan@yahoo.com  
 
Source of Monetary or Material Support  
Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India 834006 
 
Primary Sponsor  
Name  Jasar Khan 
Address  Department of Clinical Psychology, Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India 834006 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Jasar Khan  SS Raju Centre for Addiction Psychiatry, Central Institute of Psychiatry, Ranchi, 834006  Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India 834006
Ranchi
JHARKHAND 
7011326859

psy.jasar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, Central Institute of Psychiatry  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F102||Alcohol dependence, (2) ICD-10 Condition: F122||Cannabis dependence, (3) ICD-10 Condition: F142||Cocaine dependence, (4) ICD-10 Condition: F162||Hallucinogen dependence, (5) ICD-10 Condition: F182||Inhalant dependence, (6) ICD-10 Condition: F172||Nicotine dependence, (7) ICD-10 Condition: F112||Opioid dependence, (8) ICD-10 Condition: F192||Other psychoactive substance dependence, (9) ICD-10 Condition: F152||Other stimulant dependence, (10) ICD-10 Condition: F132||Sedative, hypnotic or anxiolytic-related dependence,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Integrative Psychotherapy  18 session over 6 weeks including Psychoeducation, Motivational Interviewing, Enhancing Frustration and Distress Tolerance, Emotion Regulation skills, Attachment & Mentalization based treatment, The Internal Family System (IFS),Drama Triangle, Cognitive therapy, Impulsive Lifestyle Counselling (ILC), Social Problem solving - Stop & Think, Relapse Prevention, Positive Psychology Interventions  
Comparator Agent  Treatment as Usual   Motivational Enhancement Therapy  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Male 
Details  1. Participants diagnosed using ICD 10 DCR 56 with Mental and Behavioural disorders due to use of alcohol dependence syndrome (F10.2), Opioid Dependence syndrome (F11.2) cannabinoids dependence syndrome (F12.2), sedatives or hypnotics, dependence syndrome. (F13.2), volatile solvents, dependence syndrome. (F18.2), multiple drug use and use of other psychoactive substances, dependence syndrome. (F19.2).
2. Participants with an overall PCL-R score of 20 and above.
3. Age range of 18-35 years of age.
4. Male Gender
5. Participants with at least a secondary level of education.
6. Participants who are fluent in Hindi or English language
7. Participants who consent to the research study  
 
ExclusionCriteria 
Details  1. Participants with a history of traumatic brain injury, intellectual disability or
any neurological condition, organic brain disease, and epilepsy.
2. Participants with only Nicotine Dependence.
3. Participants with impairment of hearing, vision, physical or other forms of
disability.
4. Participants with major functional mental illnesses (i.e., schizophrenia,
schizoaffective disorder, and bipolar disorder) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Difficulties in regulating emotions, Self-serving cognitive distortions and executive dysfunction  Baseline, post intervention and two months follow-up  
 
Secondary Outcome  
Outcome  TimePoints 
Craving, Readiness to change and Locus of control   Baseline, Post Intervention, and two months follow-up 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   08/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Present study seeks to investigates the role of emotional dysregulation, self-serving cognitive distortions and executive dysfunction in patients with substance use disorders (SUDs) with antisocial behaviors in a tertiary inpatient setting. Given the high prevalence of antisocial personality traits in this population and their link to poor treatment outcomes, the study compares the effectiveness of Integrative Psychotherapy combined with pharmacotherapy against standard treatment (Motivational Enhancement Therapy and pharmacotherapy). Forty male participants aged 18–35 will be randomly assigned to either group, with assessments conducted at baseline, post-intervention, and two-month follow-up. Primary outcomes include emotional regulation, executive function, and cognitive distortions, while secondary outcomes assess craving, readiness to change, and locus of control. The study aims to enhance rehabilitation outcomes by addressing underlying cognitive and emotional dysfunctions often overlooked in conventional treatments.   
Close